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Primary Isolation of Ehrlichiachaffeensisfrom Patients with Febrile Illnesses:
Clinical and Molecular Characteristics
Steven M. Standaert,1 Tina Yu,1 Margie A. Scott,1
James E. Childs,2 Christopher D. Paddock,2
William L. Nicholson,2 Joseph Singleton, Jr.,2
and Martin J. Blaser1

1Divisionof Infectious Diseases, Department of Medicine,
and Department of Pathology, VanderbiltUniversity School
of Medicine, and VA Medical Center, Nashville, Tennessee;2Division
of Viral and Rickettsial Diseases, National Centerfor Infectious
Diseases, Centersfor Disease Control and Prevention,
Atlanta, Georgia

Ehrlichia chaffeensis was sought among patients with a history of tick exposure and fever,

and the accuracy of other diagnostic tests was compared with that of primary isolation. Among
the 38 patients enrolled, E. chaffeensis was isolated from the blood of 7 (180Zo)and from
cerebrospinal fluid specimens of 2 of these 7. All 7 patients also were positive by polymerase
chain reaction (PCR) of blood, and 6 patients developed diagnostic titers of antibody to E.
chaffeensis. The isolates were characterized by molecular analysis of the 16S rRNA gene, the
120-kDa protein gene, and the variable-length PCR target (VLPT) of E. chaffeensis. On the
basis of the 120-kDa and VLPT genotypes, the cerebrospinal fluid and blood isolates from
the same patients were identical. This study demonstrates that both PCR and culture of blood
for E. chaffeensis have high diagnostic yields. More frequent isolation of E. chaffeensis from
patients with infection should further our understanding of the pathogenesis of this infection.

Infection by Ehrlichia chaffeensis may be mild or may cause
severe or fatal disease. Although human monocytotropic ehrlichiosis (HME) was first recognized in 1986 [1], it was not until
1990 that the causative organism, E. chaffeensis, was isolated
from a military recruit with a febrile illness after a tick bite
while at Fort Chaffee, Arkansas [2]. Only 8 other primary isolates have been reported subsequently [3-6], presumably because of the complex growth requirements of this obligate intracellular bacterium. In contrast, successful isolation of the
agent of human granulocytotropic ehrlichiosis (HGE), the
other common form of human ehrlichiosis in the United States,
has been reported in as many as one-third of patients with acute
infection from whom isolation has been attempted [7].
Because isolation of E. chaffeensis from clinical specimens is
rare, the accuracy of indirect diagnostic tests is unknown. More
frequent isolation of this organism also is needed to further
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define the range of clinical characteristics and the pathophysiology of infection. Therefore, we sought to determine whether
a systematic effort to culture clinical specimens from patients
with suspected HME would result in more frequent isolations
of E. chaffeensis. We attempted to define the accuracy of the
currently available diagnostic techniques by use of culture of
the organism as the reference standard for comparison. We
further sought to characterizeeach isolate by molecular analysis
of genes with known diversity [4, 5, 8, 9].

Methods
Prospectiveenrollment. Between15 April and 15 October1998,
we enrolled patients with possible tickborne infection who presented to the 3 VanderbiltUniversity-affiliatedhospitals. Enrollment criteria included fever (^37.50C), a history of tick bite or
exposure, and a clinical suspicion of tickbornerickettsialinfection
sufficientto warrantdoxycyclinetherapy.All enrolledpatientswere
interviewedwith a standard questionnaire,and their medical recordswerereviewed.Peripheralblood smearsfrom all patientswere
evaluated for the presence of intraleukocyticehrlichialinclusions
(morulae)at the time of enrollment.
For each patient, an acute-phaseserumspecimenand an EDTAanticoagulatedwhole blood specimenwere collected at the time of
presentation, and a convalescent-phaseserum specimen was obtained 4-6 weeks later. Lumbar punctureswere done for patients
whose clinical condition suggested meningitis, and a 1- to 3-mL
cerebrospinal fluid (CSF) specimen was collected for study
purposes.
PrimaryisolationofE. chaffeensis. Blood and CSF specimens
were transportedand processedfor culture immediatelyafter collection. The EDTA-anticoagulatedwhole blood specimen(2-3 mL)
was dilutedwith 2 v of sterileHanks' balancedsalt solution (HBSS;
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Life Technologies Gibco BRL, Gaithersburg,MD), layered onto
Histopaque 1083 (Sigma, St. Louis), and centrifugedat 800 g for
20 min. The leukocyte-enrichedfraction was collected and diluted
in 10 mL of HBSS and centrifugedat 400 g for 10 min. The CSF
specimenswere diluted in 10 mL of HBSS and centrifugedat 400
g for 10 min. The cell pellet was resuspendedin 4 mL of cell culture
medium,which was preparedas describedelsewhere[5]exceptthat
The cell suspension
the fetal bovine serumconcentrationwas 6.507o.
was inoculated onto a confluent layer of DH82 cells (canine peritoneal macrophage;ATCC 10389) in a 25-cm2cell culture flask
and incubated at 370Cin a 507oC02 atmosphere.The culturemedium was changed at 48 h and then twice weekly thereafterfor 60
days. Cultureswere monitored for infection by use of Leukostatstained (Fisher Scientific, Philadelphia)cytocentrifugedpreparations at least weekly for the first 30 days and serially thereafter.
Polymerasechainreaction(PCR). DNA extractionand nested
PCR of the 16S rRNA gene of E. chaffeensis,the HGE agent, and
Rickettsia rickettsiiwere done on all blood specimens (and CSF
specimenswhen available)from enrolled patients and all primary
isolates, as describedelsewhere[10], except for the addition of an
R. rickettsii species-specific primer (RR1F, CTAATTGGGGCTTGCTCCAATTAG)of our own design. Briefly, the product
from the first-roundreactionwith broad-range16S rDNA primers,
8F and 1448R [10], was used as the DNA templatefor the second
(nested)reaction.For each specimen,3 simultaneoussecond-round
reactionswere done with species-specificprimersfor E. chaffeensis,
the HGE agent, and R. rickettsiiin pairwise combination with a
primerwith enhancedspecificityfor Ehrlichiaspecies,GA1UR [10].
Both positive- and negative-controlspecimenswere tested simultaneouslywith each reaction.The positive-controlDNA specimens
were obtained from culture-derivedE. chaffeensis,the HGE agent
(provided by J. S. Dumler, Johns Hopkins University Hospital,
Baltimore),and R. rickettsii(providedby D. H. Walker,University
of Texas Medical Branch, Galveston). The negative-controlspecimens were sterile water, DNA obtained from the blood of an
uninfected person (S.M.S.), and uninfected DH82 cells. For nucleotide sequencingof the 16S rRNA gene from the patients with
PCR evidenceof E. chaffeensisinfectionand the respectiveprimary
isolates, the second-round reaction was done with primers 15F
(ATCATGGCTCAGAACGAACG) and 208R (CGTAGGCTCATCTAATAGCG)to amplifya variableregionof the gene useful
for species identification. The sequences of these products were
compared with the published sequences of the previous known
isolates of E. chaffeensis(GenBank:Arkansas, M73222; Sapulpa,
U60476; 91HE17, U23503; Jax, U86664; St. Vincent, U86665).
To further characterizeeach E. chaffeensisisolate, PCR amplification of the 120-kDa protein gene and the variable-lengthPCR
target(VLPT)gene were done on all isolates, as well as the original
blood or CSF clinical specimen from which the isolate was obtained. Both genes contain severaltandem repeat units (240 bp in
the 120-kDa protein gene and 90 bp in the VLPT gene), which
have been reportedto vary betweenstrains[5, 6, 8, 9]. All reactions
were done as describedelsewhere[5];primersFl and R2 were used
for the 120-kDaproteingene and FB3 and FB5 for the VLPT gene.
All PCR reagentswere suppliedby Qiagen (Chatsworth,CA), and
reactionswere done in a DNA thermalcycler (Perkin-Elmer,Norwalk, CT).
Serologicstudies. All serum specimensfrom enrolledpatients

were examined at the Centersfor Disease Control and Prevention
in a blinded fashion. An indirect immunofluorescenceassay was
used to identify antibodies reactive with E. chaffeensis,the HGE
agent, and R. rickettsii,as describedelsewhere[2].
Case definitions. A confirmedcase of HME, HGE, or Rocky
Mountain spotted fever (RMSF) was defined as occurringin any
patient whose blood specimen was positive by PCR testing with
species-specificprimersfor 16S rDNA or whose serum specimens
revealeda ^4-fold change in antibody titer for E. chaffeensis,the
HGE agent, or R. rickettsii,respectively[11].A culture-confirmed
case of HME was definedas occurringin any patientwhose blood
specimenyielded a primaryisolate of E. chaffeensis.
Statistical analysis. Significance tests were done with the
Mann-Whitney U test for continuous variablesand Fisher'sexact
test for dichotomous variablesperformedby use of Epi Info [12].

Results
Confirmedcases of HME. A total of 38 patients were enrolled during the 6-month study period. Of these, E. chaffeensis
was isolated from blood cultures from 7 patients (1807o),who
thus were defined as having culture-confirmed cases of HME
(table 1). We have designated these 7 E. chaffeensis isolates as
Vanderbilt 1-7 (Vl-7), on the basis of the order in which the
patients presented during the study. E. chaffeensis also was
isolated from the CSF specimens of 2 of these patients (V4C
and V6C).
Assessment of E. chaffeensis diagnostics. Each of the 7
patients with culture-confirmed HME also was positive by E.
chaffeensis-spGcilicPCR testing of whole blood (table 2). Although the true clinical specificity of the PCR is not known,
these data suggest that it is very high, because it was not positive
for any of the 31 culture-negative patients. Of the 7 patients
with confirmed HME, examination of the peripheral blood
smears revealed characteristic ehrlichial morulae in 2 (2907o).
Acute and convalescent sera were available for 34 (8907o)of
the enrolled patients. Six of the 7 patients with confirmed HME
Table1. Diagnosticfindingsfor 38enrolledstudypatientswithfebrile
illnessand historyof tick exposure.

Organism
Ehrlichiachaffeensis
HGE agent
Rickettsiarickettsii
Negative

Culture
(n = 38)

PCR
(n = 38)

T
ND
ND
31

t
0
3
28

Totalno. of
Serology subjectsin whom
(n = 34) pathogenidentified
6C
0
6d
22c

7
0
6
?

NOTE. Data (exceptfor negativeresults)are no. of patientspositiveby
diagnostictest. HGE, humangranulocyticehrlichiosis;ND, not done; PCR,
chainreaction.
polymerase
a E.
chaffeensiswas isolatedfrom both blood and cerebrospinalfluid of 2
patients.
PCRwithE. chaffeensis-sipQcific
primerswaspositivein bothbloodandCSF
of 1 patient.
c One
patient(VI) with E. chaffeensisinfectiondid not havedetectableantibody in eitheracuteor convalescentserumspecimenand is includedwithother
21dserologicallynegativepatients.
d Threeof these
patientsalso werePCR-positivefor R. rickettsii.
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Table 2. Results of nonculture methods for identification of Ehrlichia
chaffeensis in 7 patients with confirmed infection.
Serology
Peripheralblood

Acute

Convalescent

Days after
Days after
Patient Morulaea PCRb Titer symptomonset Titer symptomonset
+
VI
<32
<1
<32
48
4V2
6
4096
43
<32
+
+
V3
14
4096
2048
54
+
V4
1024
14
512
83
+
+
V5
<32
3
4096
43
+
V6
<32
3
4096
50
+
V7
<32
4
1024
53
a Presenceof morulaeon examinationof
of
smear
Wright-stained
peripheral
blood. - , negative;4-, positive.
Polymerasechainreactionof wholeblood specimen.

developed diagnostic antibody titers within 14-43 days of the
onset of illness (range of reciprocal titers, 512-^096; table 2).
One patient (VI) with confirmed HME who had received doxycycline therapy during the first 12 h after the onset of fever
never developed diagnostic serum titers of antibody to E.
chaffeensis.
In addition to the cases of HME, there were 6 (1607o)confirmed cases of RMSF and no cases of HGE (table 1). Among
the remaining 25 patients, there was no evidence of infection
with E. chaffeensis, the HGE agent, or R. rickettsii by any
modality; only the 21 patients for whom both acute and convalescent specimens were available were used for subsequent
comparisons.
Clinical and epidemiologicfeatures of HME cases. All cases
of HME occurred between late April and the first week of
August, whereas the cases of RMSF extended to late September
(figure 1). The patients with HME originated from four counties
in Tennessee and a single county in Kentucky, and there was
no geographic clustering of cases. There were no significant
differences in demographic characteristics between patients
with HME, patients with RMSF, and those without either infection, although 12 (9207o)of the 13 patients with either HME
or RMSF were male and 10 (7707o)required hospitalization
(table 3). A nonspecific, fleeting maculopapular rash on the
face and neck occurred in 2 patients with HME (2307o),whereas
a typical petechial rash occurred in 4 patients with RMSF
(6707o).A nonspecific maculopapular rash occurred in 6 patients
for whom no infecting agent was identified. The only laboratory
findings that were significantly different between patients with
HME and those without either HME or RMSF were the degree
of thrombocytopenia and the proportion with elevated serum
aspartate aminotransferase. However, 7107oof patients with
HME had leukopenia and none had an abnormally elevated
white blood cell count.
Of the 21 patients without either HME or RMSF, a definitive
diagnosis was determined for only 2; 1 patient had Staphylococcus aureus bacteremia and the other patient had AIDS and
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acute hepatitis A virus infection. There were no deaths among
the patients enrolled in the study.
Characteristics of the primary isolation of E. chaffeensis.
For the 9 samples that yielded E. chaffeensis, the median time
between collecting the blood and CSF specimens from patients
and inoculating the leukocyte-enriched fraction into cell culture
was 3 h (range, 1-18). This interval did not differ from that
for the 31 culture-negative patients (median, 3 h; range, 1-10).
Primary isolation of ehrlichiae from the blood specimens, as
evidenced by visualization of morulae in the cytoplasm of
DH82 cells, occurred between 2 and 12 days (median, 11) after
inoculation. There was no significant relationship between the
rapidity of inoculation and either the success or rapidity of
primary isolation in cell culture (data not shown). Of the 2
isolates from CSF, 1, from a patient (V4) with obvious meningitis (310 white blood cells/mm3), was seen 16 days after cell
culture inoculation. In contrast, in patient V6, in whom only
a single CSF white blood cell and no red blood cells were
present, E. chaffeensis was isolated 50 days after cell culture
inoculation.
Molecular characteristics ofE. chaffeensis isolates. Nested
PCR with the E. chaffeensis-specific primers HE1 and GA1UR
and DNA extracts of the 9 isolates from all 7 patients yielded
the characteristic 389-bp 16S rRNA gene product (data not
shown). The nucleotide sequence of the variable 190-bp region
of the 16S rRNA gene (as determined by use of primers 15F
and 208R) from each patient's blood specimen and the 7 isolates
was identical to the GenBank sequence for the previous E.
chaffeensis isolates.
PCR amplification of the 120-kDa protein gene and the
VLPT gene produced amplicons varying from ~1000 to 1500
bp and 369 to 539 bp, respectively, from the 9 isolates (table
4). The number of repeat units, as inferred from the size of
these products, ranged from 2 to 4 repeats for the 120-kDa
protein gene and 3 to 5 repeats for the VLPT gene (table 4).
Nucleotide sequencing of the VLPT gene PCR products confirmed these findings (data not shown). Because of the large
size of the 120-kDa gene, confirmatory nucleotide sequencing
was not done. On the basis of the number of repeats of these
2 genes, 5 distinct molecular patterns were observed among the
9 isolates. For each patient, the PCR product obtained directly
from the blood had the same apparent migration as the product
obtained from the corresponding E. chaffeensis isolate (figure
2); the product from each of the CSF isolates also was identical
to that of the corresponding blood isolate.

Discussion
Primary isolation of E. chaffeensis from infected patients has
been difficult. Attempts to isolate the organism have been limited by the requirementfor antibiotic-free cell culture techniques
and a concern for the potential risk of laboratory-acquired
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Month of Presentation

A. americanum
life-cycle

Adults and Nymphs
Larvae

Figure 1. Distributionof febriletickborneillnessamong 38 enrolledpatientsfrom 15 Aprilto 15 October1998,Nashville.Seasonalchanges
of life-cyclestagesof Amblyomma
americanum,
likelytick vectorfor Ehrlichiachaffeensis,are indicatedby arrowsbelow graph.E. chaffeensisis
not believedto be passedtransovarially
withintick,andthereforeonly adultsandnymphsarepotentiallyinfectious.HME,humanmonocytotropic
ehrlichiosis;RMSF,Rocky Mountainspottedfever.

infections, as has been reported with R. rickettsii [13]. Despite
numerous attempts, only 9 primary isolates have been described
in the previous 8 years [2-6]. In this study, E. chaffeensis was
isolated from blood specimens from 7 patients in one locale
over a 6-month period; isolation was 10007osensitive, on the
basis of both PCR and serologic criteria. The time to culture
positivity was substantially shorter in this study (median, 11
days) than reported for the other E. chaffeensisisolates (median,
20 days) [2-5]. This rapidity likely was due to the proximity of
our laboratory to the patients, resulting in brief (median, 3-h)
intervals until specimen inoculation in cell culture. Although
isolation of E. chaffeensis was not more likely when culture
inoculation occurred early within the 18-h range, the preinoculation time likely was much longer for previous E. chaffeensis
isolation attempts, given the inherent delays in transporting
clinical specimens to researchcenters. The proximity of infected
patients to a specialized research laboratory probably also contributed to the first successful isolation of the HGE agent [14].
The lower concentration (6.507o)of fetal bovine serum used in
our cell culture media compared with previous efforts
(8.807o-1207o)
[2-6] may have contributed to E. chaffeensis isolation, as suggested elsewhere [3].
Despite the high sensitivity of primary isolation of E. chaffeensis from clinical specimens, the required technical expertise
and prolonged incubation time may curtail its widespread diagnostic use. However, we and others [15, 16] have found PCR
to be both rapid and accurate for diagnosing E. chaffeensis
infections and, thus, useful in initial patient management. PCRbased techniques are increasingly becoming standardized and
clinically available. In contrast, the sensitivity of early serologic
testing for E. chaffeensisinfection is poor, because only 2 (2907o)
of the 7 patients with confirmed HME in our series had de-

tectable antibody levels on initial presentation, and both patients already had been ill for 14 days. Despite the rapidity and
increased sensitivity of PCR testing, empirical therapy with
doxycycline should be administered immediately without waiting for the results of diagnostic testing, because any delay in
therapy can lead to increased morbidity and mortality [17].
The improved sensitivity of the nested PCR protocol we used
may be offset by an increased risk of contamination, because
specimens must be handled more frequently. Nonetheless, we
chose to use this technique during our study for 2 reasons.
First, the same 16S rDNA amplicon from the first reaction can
be used as the template for subsequent reactions to test for
several different organisms simultaneously. In addition, we have
found that a nested reaction is required to detect R. rickettsii
from blood specimens, because the number of organisms in
peripheral blood is so few. As with any laboratory test, simultaneous reactions with adequate positive and negative control specimens are essential. Laboratories that handle a large
number of clinical specimens may find that a nested protocol
is too problematic to be used for routine diagnostic purposes.
However, our data indicate that this approach is feasible, especially when the PCR amplicon identity is confirmed by nucleotide sequencing.
All patients with E. chaffeensis infection became ill between
late April and the first week of August (figure 1). A similar
seasonal distribution of HME in Tennessee has been noted
earlier [15] and may reflect the seasonal activities of the tick
vector, Amblyomma americanum [18, 19]. E. chaffeensis is not
believed to be passed transovarially within the tick, and therefore only the adults and nymphs are potentially infectious.
Questing A. americanum adults and nymphs are present from
early spring to midsummer in Tennessee, but beyond August
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Table 3. Demographic characteristics and laboratory results for 34 study patients
with history of tick exposure by tickborne illness.
Demographicor
clinicalcharacteristic
or laboratoryvalue
Age, years
No. male
No. hospitalized
No. with reportedtick bite
No. with rash
Whiteblood cell count,
cells X 103/mm3
No. with leukopenia(<4.5 X 103
whiteblood cells/mm3)
Hematocrit,%
No. with anemia(for age and sex)
Plateletcount,cells X 103/mm3
No. with thrombocytopenia
(<150 X 103platelets/mm3)
Serumaspartate
aminotransferase
level,IU
No. with abnormalserum
aspartateaminotransferase
value(>40IU)
Bilirubinlevel,mg/dL
No. with abnormalbilirubin
value(>1.0mg/dL)

Human
monocytic
ehrlichiosis
(n = 7)
36 (10-57)
6
5
4
2
2.1 (1.4-7.5)
5
37 (31-45)
4
75 (37-206)a
6

RockyMountain
spottedfever
(n = 6)
33 (0.6-69)
6
5
2
4
10.2(1.4-16.8)
1
40 (32^13)
2
159 (21-367)
3

155 (52-281)b

54 (17-167)

No agent
identified
(? = 21)
37 (7-72)
11
12
7
6
5.1 (1.9-11.5)
9
41 (29-48)
8
167 (62-327)
10
36 (17-2173)

7a
2.3 (0.7-5.3)

3
1.0 (0.4-3.1)

5C
0.7 (0.2-6.5)

4

2

4C

NOTE. Data with parenthesesare median(range).Onlyacuteserumspecimenswereobtainedfrom4 patients,and they wereexcludedfromoriginal38 patients.All 4 werenegative
by cultureand polymerasechainreactionfor organismsof interest.
a P<.05 vs. patientswith no agentidentified.
bnP*c.05vs. patientswith RockyMountainspottedfever.
c Determinedfor
only 11 patients.

only larvalticks can be found. In contrast,the adult stage of
Dermacentorvariabilis,the predominantvectorof R. rickettsii
in Tennessee,is presentlateinto the fall [20],whichis consistent
with our identificationof patientswith RMSF in September.
Meningitishas been increasinglyrecognizedas a featureof
E. chaffeensisinfection [21, 22]. Although E. chaffeensishas
beendetectedin CSF by PCR [23],we now reportits isolation.
Lumbarpuncturewas done for only 2 of the 7 patientswith
E. chaffeensisinfection,and a primaryisolate identicalto the
blood isolate was recoveredfrom both specimens.Since 1 of
these patients(V6) had no laboratoryevidenceof meningitis,
the frequencyof E. chaffeensisinvasionof the CSFduringacute
infectionand then its elimination,eitherby antibiotictherapy
or the host immune response, is unknown. The findingsin
patientV6, that PCR yieldednegativeresultsand culturerequired 50 days, suggestthat the actual numberof Ehrlichiae
in the CSF was small. Although contaminationof the CSF
with the blood isolate duringthe lumbarpuncturemay have
occurred,we believethis to be unlikely,becauseno red blood
cells were detectedin the CSF specimenfrom this patient.
E. chaffeensisisolatesare polymorphicin the numberof repetitivesequenceswithinthe genes encodingthe 120-kDasurface proteinand VLPT[4-6, 8, 9], and the isolateswe obtained
illustratethis phenomenon.IsolateV5 had only 2 repeatunits
in the 120-kDagene, a novel finding(table4). On a practical

level, these studies are useful by indicatingthat neitherthe
initialdiagnosticPCR resultsnor the isolatedorganismswere
falsely positive as a result of contaminationwith laboratory
strainsof E. chaffeensis.From a biologic and epidemiologic
perspective,furtherstudyof the geneticpolymorphismsof the
VLPT and the 120-kDaproteingenes would be interestingto
determineif they can be correlatedwith pathogenicityor geographicdistributionof differentstrains.Severalpathogenicorganisms,includingRickettsiaspecies,have genes with repeat
Table 4. Size variation in 120-kDa protein gene and variable-length
polymerase chain reaction (PCR) target (VLPT) gene in 18 known
Ehrlichia chaffeensis isolates.

Previousisolate[ref.]
Wakulla[6]
91HE17[3]
Arkansas,Jax, Liberty
[2, 5, 6]
St. Vincent,Sapulpa,
WestPaces[4, 5]
Osceola[6]

New
isolate

No. of repeatsa
120-kDaprotein

VLPT

V7

4
4

6
5

VI, V4b

4

4

V3
V2, V6b
V5

3
3
2

3
4
4

a As determined nucleotide
by
sequencingfor VLPTand from size of PCR
productfor 120-kDagene (figure2).
fluidandbloodisolatesshowedidentical
Forindividualpatient,cerebrospinal
patternsby PCR.
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Figure 2. Variationof no. of tandemrepetitivesequencesin 120-kDaproteingeneandvariablelengthpolymerasechainreaction(PCR)target
of PCR productsof clinicalspecimens(lanesB, wholeblood;lanesC, cerebrospinal
fluid[CSF])
(VLPT)identifiedby agarosegel electrophoresis
frompatientsV7, V4, and V3 and correspondingEhrlichiachaffeensisisolates(lanesI) fromculturein DH82 cells. PatientV4 had meningitis,
and isolate(Ic) was obtainedfromCSF.Both genesencodevariablenumberof tandemrepeatsthat varybetweenstrains.Arrowsrepresentno.
of repeat units observedfor 120-kDa protein gene (4 repeats-^ 1500 bp, 3 repeats-- 1250 bp) and VLPT gene (5 repeats- 549 bp, 4
E. chaffeensis
repeats^ 459 bp, 3 repeats= 369 bp). Ampliconsizesof clinicalblood and CSF specimensareall identicalto that of corresponding
cultureisolate from that specimen,indicatingthat isolatedstrainwas detectedby directPCR of clinicalspecimens.Nos. of repeatunits noted
for genesare independentof each other:for example,ampliconsizesfor 120-kDaproteingene areidenticalin all specimensfrompatientV7 and
V4, but sizes of VLPTampliconsare different.Lane L, molecularsize standardladder;lane N, negativecontrol(uninfectedDH82 cells).

domains that encode for surface proteins involved in antigenic
variation and possibly in adherence to host cells [24-27]. We
and others have found no geographic clustering of E. chaffeensis strains on the basis of the genotypes examined, although
the number of samples examined is low [5, 6, 9]. In addition,
none of the patterns observed among the 7 new isolates was
predictive of a particular clinical outcome. Further analysis of
these potential relationships may be more revealing as we increase the number of isolates from infected patients.
One-third of the patients enrolled in this study were found
to have a tickborne rickettsial infection, either HME or RMSF.
Equally provocative, however, is the cause of illness in the 19
patients without an identifiable rickettsial or other known infection. All recovered from their illness without consequence,
and several appeared to respond to doxycycline therapy. Yetto-be-identified organisms that infect humans could be contributing to this group of undefined, apparently doxycyclineresponsive febrile illnesses [28]. The development of molecular
tools, such as broad-range PCR primers, may permit identification of novel rickettsial (including Ehrlichia) species in
humans.
This study represents the first systematic effort to isolate E.
chaffeensis from patients with febrile illness following tick exposure. In contrast to previous investigations, we were able to
isolate the organism from each patient in our study who had
any evidence of E. chaffeensis infection. Because the diagnostic
accuracy of the other available modalities (detection of morulae, PCR, and serology) has not been defined, the ability to
readily culture the organism now can serve as a reference stan-

dard for comparison. Although the prolonged time for culture
(median, 11 days) precludes its application for rapid diagnosis,
examination of peripheral blood by means of PCR and staining
may be clinically useful. Finally, our demonstration of the feasibility of culturing E. chaffeensis directly from patient blood
and CSF specimens should improve understanding of the phylogeny of this organism and the epidemiology and pathogenesis
of infection.
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